Nisa Investment Advisors
LYRA

Nisa Investment Advisors’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Nisa Investment Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$90 – 3045
2025
Q2 		$90 Hold
10
– – ﹤0.01% 3031
2025
Q1 		$63 Hold
10
– – ﹤0.01% 2973
2024
Q4 		$103 Buy
10
+9
+900% +$99 ﹤0.01% 2982
2024
Q3 		$10 Buy
+1
New +$15 ﹤0.01% 2955
2020
Q4 		– Sell
-324
Closed -$181K – 2317
2020
Q3 		$181K Buy
+324
New +$201K ﹤0.01% 1341

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nisa Investment Advisors's LYRA Position: Q3 2025 in Review

Nisa Investment Advisors sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2025, closing a stake of 10 shares — an estimated $90 sold.

Nisa Investment Advisors first reported a position in LYRA in Q3 2020 and held it in 5 quarters. The position peaked at $181K in Q3 2020. 26 funds tracked by Wall St. Rank hold LYRA as of Q3 2025.

  • Nisa Investment Advisors reported no remaining LYRA THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 10 LYRA THERAPEUTICS INC shares in Q3 2025, an estimated $90.
  • Nisa Investment Advisors first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 5 quarters.
  • Nisa Investment Advisors's LYRA THERAPEUTICS INC position peaked at $181K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.